Skip to content
Disclosery

WAYCROSS PARTNERS, LLC: CME position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of WAYCROSS PARTNERS, LLC on CME, newest first. How the timeline and the estimate are built.

WAYCROSS PARTNERS, LLC held 1,344 CME shares at 2026-06-30 per its 13F-HR filed 2026-08-11.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 1,344 shares
    Change vs previous 13F 0 shares

    0.03% of the 13F portfolio, value $296,796.

    13F-HR 0001844873-26-000008 filed by WAYCROSS PARTNERS, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 1,344 shares
    Change vs previous 13F 0 shares

    0.04% of the 13F portfolio, value $396,950.

    13F-HR 0001844873-26-000005 filed by WAYCROSS PARTNERS, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 1,344 shares
    Change vs previous 13F 0 shares

    0.03% of the 13F portfolio, value $367,020.

    13F-HR 0001844873-26-000001 filed by WAYCROSS PARTNERS, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 1,344 shares
    Change vs previous 13F 0 shares

    0.03% of the 13F portfolio, value $363,135.

    13F-HR 0001844873-25-000008 filed by WAYCROSS PARTNERS, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 1,344 shares
    Change vs previous 13F not available

    0.03% of the 13F portfolio, value $370,433.

    13F-HR 0001844873-25-000004 filed by WAYCROSS PARTNERS, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).